company background image
CBL logo

Control Bionics ASX:CBL Stock Report

Last Price

AU$0.052

Market Cap

AU$10.6m

7D

18.2%

1Y

-41.6%

Updated

24 Jun, 2024

Data

Company Financials

CBL Stock Overview

Engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America.

CBL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Control Bionics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Control Bionics
Historical stock prices
Current Share PriceAU$0.052
52 Week HighAU$0.093
52 Week LowAU$0.033
Beta-0.00047
11 Month Change8.33%
3 Month Change9.47%
1 Year Change-41.57%
33 Year Change-92.41%
5 Year Changen/a
Change since IPO-95.59%

Recent News & Updates

Recent updates

Companies Like Control Bionics (ASX:CBL) Are In A Position To Invest In Growth

Jan 19
Companies Like Control Bionics (ASX:CBL) Are In A Position To Invest In Growth

We're Hopeful That Control Bionics (ASX:CBL) Will Use Its Cash Wisely

Sep 17
We're Hopeful That Control Bionics (ASX:CBL) Will Use Its Cash Wisely

Shareholder Returns

CBLAU Medical EquipmentAU Market
7D18.2%0.9%0.8%
1Y-41.6%25.8%10.3%

Return vs Industry: CBL underperformed the Australian Medical Equipment industry which returned 25.8% over the past year.

Return vs Market: CBL underperformed the Australian Market which returned 10.3% over the past year.

Price Volatility

Is CBL's price volatile compared to industry and market?
CBL volatility
CBL Average Weekly Movement15.5%
Medical Equipment Industry Average Movement9.3%
Market Average Movement8.3%
10% most volatile stocks in AU Market16.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: CBL's share price has been volatile over the past 3 months.

Volatility Over Time: CBL's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2005n/aJeremy Steelewww.controlbionics.com

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that can be used with a Windows display device; NeuroNode, a wireless wearable sensor that gives the user the ability to access their technology by bioelectric signals or spatial movements; Uno Touch, a speech generating device; NeuroNode Duo, a wireless sensor; and Eye gaze Duo that allows the user to control a computer mouse with their eyes.

Control Bionics Limited Fundamentals Summary

How do Control Bionics's earnings and revenue compare to its market cap?
CBL fundamental statistics
Market capAU$10.56m
Earnings (TTM)-AU$4.82m
Revenue (TTM)AU$5.71m

1.8x

P/S Ratio

-2.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CBL income statement (TTM)
RevenueAU$5.71m
Cost of RevenueAU$1.51m
Gross ProfitAU$4.20m
Other ExpensesAU$9.02m
Earnings-AU$4.82m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.024
Gross Margin73.53%
Net Profit Margin-84.45%
Debt/Equity Ratio0%

How did CBL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.